TSXV - Free Realtime Quote CAD
Rakovina Therapeutics Inc. (RKV.V)
0.0500
0.0000
(0.00%)
As of 10:30:41 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 18.25M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Bacha (Jeffrey) Senior Officer of Issuer | Acquisition or disposition in the public market at price 0.04 per share. | Direct | 2,000 | Apr 11, 2025 |
| De Lucrezia (Alfredo) Director of Issuer | Acquisition or disposition in the public market at price 0.05 per share. | Direct | 637 | Jan 8, 2025 |
| Bacha (Jeffrey) Senior Officer of Issuer | Other at price 0.07 per share. | Direct | 2,100 | Dec 31, 2024 |
| De Lucrezia (Alfredo) Director of Issuer | Other at price 0.07 per share. | Direct | 2,100 | Dec 31, 2024 |
| De Lucrezia (Alfredo) Director of Issuer | Acquisition or disposition in the public market at price 0.13 per share. | Direct | 17,490 | Dec 31, 2024 |
| Liggett (Michael) Director of Issuer | Acquisition or disposition in the public market at price 0.10 per share. | Direct | 5,200 | Dec 19, 2024 |
| De Lucrezia (Alfredo) Director of Issuer | Acquisition or disposition in the public market at price 0.05 per share. | Direct | 4,752 | Oct 25, 2024 |
| De Lucrezia (Alfredo) Director of Issuer | Acquisition or disposition in the public market at price 0.05 per share. | Direct | 2,592 | Oct 21, 2024 |
| De Lucrezia (Alfredo) Director of Issuer | Acquisition or disposition in the public market at price 0.05 per share. | Direct | 756 | Oct 18, 2024 |
| Bacha (Jeffrey) Senior Officer of Issuer | Acquisition or disposition in the public market at price 0.08 per share. | Direct | 2,025 | Oct 3, 2024 |
| Bacha (Jeffrey) Senior Officer of Issuer | Other at price 0.06 per share. | Direct | 2,175 | Jul 2, 2024 |
| De Lucrezia (Alfredo) Director of Issuer | Other at price 0.06 per share. | Direct | 2,175 | Jul 2, 2024 |
| Daugaard (Mads) Senior Officer of Issuer | Acquisition or disposition in the public market at price 0.07 per share. | Direct | 1,750 | May 16, 2024 |
Related Tickers
SVA.TO Sernova Biotherapeutics Inc
0.2000
-2.44%
APLI.TO Appili Therapeutics Inc.
0.0300
0.00%
SANNz.XC
ENBI.CN Entheon Biomedical Corp.
0.1150
0.00%
REGN.VI Regeneron Pharmaceuticals, Inc.
497.60
+1.55%
SEOVF Sernova Biotherapeutics Inc
0.1500
+2.74%
IBO Impact BioMedical Inc.
0.4563
+8.72%
EPRX Eupraxia Pharmaceuticals Inc.
3.7000
+6.17%
GNFT Genfit S.A.
3.5900
+4.06%
EPRX.TO Eupraxia Pharmaceuticals Inc.
5.08
+4.96%